Skip to content
10-Q

Quarterly Report

TALON THERAPEUTICS, INC.

0001437749-12-011758

← back to feed
Filed
Nov 14, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Stock Issued Q3 2012 · Nov 14, 2012 30K sh
Stock Issued Q3 2012 · Jul 5, 2012 36.7K sh
Stock Issued Q3 2012 · Jan 9, 2012 10.75K sh
Shares Outstanding Q3 2012 · Nov 13, 2012 22M sh
Shares Diluted Q3 2012 · Sep 30, 2012 161.79K sh
Shares Diluted Q3 2012 · Sep 30, 2012 21.9K sh
Shares Diluted restated Q3 2012 · Sep 30, 2011 21.78K sh
Shares Diluted restated Q3 2012 · Sep 30, 2011 21.47K sh
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$14.69M
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$18.29M
Cash And Equivalents Q3 2012 · Sep 30, 2012 $5.56M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $1.03M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $4.58M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $4.57M
Stockholders Equity Q3 2012 · Sep 30, 2012 −$96.26M
Stockholders Equity Q3 2012 · Dec 31, 2011 −$59.02M
Current Liabilities Q3 2012 · Sep 30, 2012 $3.41M
Current Liabilities Q3 2012 · Dec 31, 2011 $4.56M
Total Liabilities Q3 2012 · Sep 30, 2012 $57.94M
Total Liabilities Q3 2012 · Dec 31, 2011 $30.87M
Current Assets Q3 2012 · Sep 30, 2012 $5.99M
Current Assets Q3 2012 · Dec 31, 2011 $1.66M
Total Assets Q3 2012 · Sep 30, 2012 $6.62M
Total Assets Q3 2012 · Dec 31, 2011 $2.49M
Eps Diluted Q3 2012 · Sep 30, 2012 $0.18
Eps Diluted Q3 2012 · Sep 30, 2012 −$3.14
Eps Diluted Q3 2012 · Sep 30, 2011 −$0.08
Eps Diluted Q3 2012 · Sep 30, 2011 −$0.94
Eps Basic Q3 2012 · Sep 30, 2012 $1.35
Eps Basic Q3 2012 · Sep 30, 2012 −$3.14
Eps Basic Q3 2012 · Sep 30, 2011 −$0.08
Eps Basic Q3 2012 · Sep 30, 2011 −$0.94
Sga Expense Q3 2012 · Sep 30, 2012 $2.06M
Sga Expense Q3 2012 · Sep 30, 2012 $5.24M
Sga Expense Q3 2012 · Sep 30, 2011 $964K
Sga Expense Q3 2012 · Sep 30, 2011 $3.72M
Rd Expense Q3 2012 · Sep 30, 2012 $5.33M
Rd Expense Q3 2012 · Sep 30, 2012 $10.25M
Rd Expense Q3 2012 · Sep 30, 2011 $2.39M
Rd Expense Q3 2012 · Sep 30, 2011 $11.06M
Net Income Q3 2012 · Sep 30, 2012 $40.5M
Net Income Q3 2012 · Sep 30, 2012 −$50.79M
Net Income Q3 2012 · Sep 30, 2011 −$706K
Net Income Q3 2012 · Sep 30, 2011 −$17.17M
Operating Income Q3 2012 · Sep 30, 2012 −$7.39M
Operating Income Q3 2012 · Sep 30, 2012 −$15.48M
Operating Income Q3 2012 · Sep 30, 2011 −$3.35M
Operating Income Q3 2012 · Sep 30, 2011 −$14.78M
Capex Q3 2012 · Sep 30, 2011 $70K